Haleon PLC closed 11.49% below its 52-week high of £4.20, which the company reached on May 30th.

Haleon PLC closed 9.92% short of its 52-week high of £4.20, which the company achieved on May 30th.

See the latest Haleon PLC ADR stock price (HLN:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 ...

Review quarterly and annual revenue, net income, and cash flow for Haleon PLC ADR (HLN:XNYS) stock through the last fiscal year.

The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also raised its financial forecasts for the full year for the second time in consecutive ...

AK&M 03 July 2025 05:15 The American multinational pharmaceutical company Pfizer Inc. plans to sell 700 million shares of Haleon Plc (7.7%) as part of accelerated book building. This is reported in a ...

Susan Gu, general manager for the Chinese mainland and Hong Kong at Haleon. [Photo/China Daily] Haleon plc, a global leader in the consumer health sector, is optimistic about China's economy and will ...

The booth of Haleon in the exhibition area of the medical equipment and healthcare products at the 5th CIIE in Shanghai, Nov 8, 2022. [Photo/IC] Consumer health company Haleon aims to grasp ...